June 26, 2020 / 12:18 PM / 11 days ago

J&J scraps late-stage study testing Stelara for lupus

June 26 (Reuters) - Johnson & Johnson’s Janssen unit said on Friday it would discontinue a late-stage study testing its psoriatic arthritis drug Stelara as a treatment for lupus due to lack of efficacy.

Systemic Lupus Erythematosus, or lupus, is a chronic disease that causes inflammation in connective tissues, such as cartilage and the lining of blood vessels. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Saumyadeb Chakrabarty)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below